Over the course of three days, experts in drug screening from around the globe will assemble to discuss the latest applications of Cisbio’s proprietary HTRF® technology in the drug screening, target discovery and mechanistic fields.  A number of scientific sessions will specifically examine GPCR and kinase screening, cell-based biomarker detection and functional assays. 

 

HTRF® (homogenous time-resolved fluorescence) technology is a highly sensitive, robust technology for the detection of molecular interactions and is widely used for the high throughput stage of drug development. As part of its ongoing commitment to providing the highest quality technical support to HTRF® customers, Cisbio established its annual symposium in 2005 as a forum for exchanging ideas on drug screening and the latest in HTRF® innovation